[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362628-105":59,"doc-detail-362628-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","applying-microfluidic-technology-to-interpret-the-tumor-immune-microenvironment-and-cancer-immunotherapy","Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy","","Cancer immunotherapy has become a transformative option across malignancies, yet many patients respond poorly. The tumor immune microenvironment (TIME), with its complex architecture and cellular composition, strongly shapes clinical outcomes. Microfluidic technology enables in vitro recapitulation of dynamic TIME crosstalk by manipulating microscale fluids. Microfluidic chips allow real-time monitoring and analysis of cell behavior, signaling, and tumor–immune interactions, supporting bulk-cell to single-cell interpretations. This review surveys chip design and translational applications in biomarker discovery, high-throughput drug screening, personalized immunotherapy development, and current limitations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/applying-microfluidic-technology-to-interpret-the-tumor-immune-microenvironment-and-cancer-immunotherapy/362628/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/applying-microfluidic-technology-to-interpret-the-tumor-immune-microenvironment-and-cancer-immunotherapy/362628.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is modeling the tumor immune microenvironment (TIME) important for immunotherapy research?","Question",{"text":112,"@type":113},"The TIME’s architecture and cellular composition substantially influence clinical outcomes and determine how tumor and immune cells interact during treatment. Accurate models help interpret this dynamic complexity and evaluate drug efficacy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What advantages do microfluidic technologies offer compared with traditional models?",{"text":117,"@type":113},"Microfluidic systems mimic dynamic TIME crosstalk by controlling microscale fluid manipulation in integrated devices. They enable real-time monitoring of cellular functions, signaling, and tumor–immune interactions, including temporal and spatial dynamics.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitations affect conventional in vivo animal models and Transwell systems?",{"text":121,"@type":113},"Animal experiments are time-consuming, costly, ethically challenging, and cannot fully replicate human pathology. Transwell models are partly mediated by gravity and often fail to represent fluid characteristics and the temporal and spatial dynamics relevant to immunotherapy efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362628,1791052809,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Cancer Biol Med 2026. doi: 10.20892/j.issn.2095-3941.2025.0541  \nREVIEW  \nApplying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy  \nXuhong Chen, Dongxian Tan, Shuaiting Liu, Ruolin Luo, Yang Liu, Miaomiao Zhang, Siqi Li, Jing Xu  \nMedical Research Center, Southern University of Science and Technology Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China  \n\n| ABSTRACT | In the past decade, cancer immunotherapy has emerged as a transformative treatment modality for diverse malignancies. Although |\n| --- | --- |\n| KEYWORDS | impressive clinical efficacy has been demonstrated in some cancer patients, most patients respond poorly to immunotherapies. The complicated architecture and cellular composition of the tumor immune microenvironment (TIME) have substantial roles in the clinical outcomes of immunotherapies. Therefore, employing optimal in vitro models recapitulating the in vivo TIME characteristics is particularly important for interpreting the dynamic complexity of the TIME, evaluating drug efficacy, and developing novel immunotherapeutics. In recent years, microfluidic technology has been shown to be a valuable tool for mimicking dynamic crosstalk among the TIME in vitro through the manipulation of microscale fluids in an integrated device. Cellular behaviors, function and signal transduction, and tumor–immune interactions can be monitored in real time and analyzed in microfluidic chips by combining visualization technologies. Numerous recent studies have shown how to design and fabricate microfluidic chips for reproducing the complex three-dimensional architecture and dynamic changes in the TIME. This review comprehensively examines the application of innovative microfluidic technology in the field of cancer immunology research, focusing on interpreting dynamic crosstalk inside the TIME from bulk-cell to single-cell analyses, evaluating the efficacy of novel immunotherapies and preparing immunotherapeutic agents, and analyzes current limitations. This work aimed to propose a translational roadmap for leveraging microfluidics in elucidating mechanisms, biomarker discovery, high-throughput drug screening, and personalized immunotherapy development. Microfluidic chip; tumor immune microenvironment; immunotherapy; cell‒cell interactions; cancer immunology |\n\nIntroduction  \nCancer is a global threat to human health1. In addition to traditional treatments, including surgery, radiotherapy, chemotherapy, and targeted therapy, immunotherapy ranks among the top 10 scientific breakthroughs according to Science in 20132 and has increasingly become a treatment option for some cancer patients3,4 . Immune checkpoint blockade (ICB) therapy and cellular immunotherapy are promising cancer treatments that prolong the survival of cancer patients by activating or adaptively enhancing the immune system to attack tumor cells. Although impressive therapeutic outcomes have been achieved in multiple cancer types5-7, most patients, especially  \nCorrespondence to: Jing Xu E-mail: [xuj2020@mail.sustech.edu.cn](xuj2020@mail.sustech.edu.cn)  \nORCID ID: [https://orcid.org/0000-0002-2035-3482](https://orcid.org/0000-0002-2035-3482)  \nReceived September 28, 2025; accepted December 15, 2025;  \npublished online February 17, 2026. Available [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2026 The Authors. Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4 .0)  \npatients with solid tumors, exhibit poor or partial responses to immunotherapies8-11. Therefore, exploring the mechanisms underlying primary or acquired drug resistance to immunotherapy and developing effective methods to evaluate the efficacy of novel immunotherapeutics are particularly important.  \nThe tumor microenvironment (TME) is believed to co-evolve with tumor cells and modulate nearly every aspect of tumor progression. Complicated crosstalk among TME cells (fibrobla","cbCaitbOPqiSpE7L","https://ap.wps.com/l/cbCaitbOPqiSpE7L","pdf",1319213,17,"English","# Introduction\n## Immunotherapy and treatment resistance\n## Tumor microenvironment and TIME crosstalk\n## Limitations of traditional in vivo and 2D/3D models\n## Rationale for microfluidic chips in tumor immunology","[{\"question\":\"Why is modeling the tumor immune microenvironment (TIME) important for immunotherapy research?\",\"answer\":\"The TIME’s architecture and cellular composition substantially influence clinical outcomes and determine how tumor and immune cells interact during treatment. Accurate models help interpret this dynamic complexity and evaluate drug efficacy.\"},{\"question\":\"What advantages do microfluidic technologies offer compared with traditional models?\",\"answer\":\"Microfluidic systems mimic dynamic TIME crosstalk by controlling microscale fluid manipulation in integrated devices. They enable real-time monitoring of cellular functions, signaling, and tumor–immune interactions, including temporal and spatial dynamics.\"},{\"question\":\"What limitations affect conventional in vivo animal models and Transwell systems?\",\"answer\":\"Animal experiments are time-consuming, costly, ethically challenging, and cannot fully replicate human pathology. Transwell models are partly mediated by gravity and often fail to represent fluid characteristics and the temporal and spatial dynamics relevant to immunotherapy efficacy.\"}]","Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy | PDF",1790148614,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d270195f6dd72eeaa667e58592e4fd1.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7cebd83fb90a5a5a70fc86705850e57.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96f38ea0c927a769adb39e6fe3aed9c1.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a07d0b6d85e121a14b17510f594b540.webp",980,1283]